Deciphering the Importance of Glycosphingolipids on Cellular and Molecular Mechanisms Associated with Epithelial-to-Mesenchymal Transition in Cancer

被引:32
|
作者
Cumin, Cecile [1 ]
Huang, Yen-Lin [1 ]
Everest-Dass, Arun [2 ]
Jacob, Francis [1 ]
机构
[1] Univ Basel, Univ Hosp Basel, Dept Biomed, Ovarian Canc Res, CH-4031 Basel, Switzerland
[2] Griffith Univ, Inst Glyc, Gold Coast, Qld 4215, Australia
关键词
epithelial-to-mesenchymal transition; (EMT; MET); glycosphingolipids; gangliosides; globosides; cell migration; invasion; tumor growth; signal transduction; metastasis; GROWTH;
D O I
10.3390/biom11010062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Every living cell is covered with a dense and complex layer of glycans on the cell surface, which have important functions in the interaction between cells and their environment. Glycosphingolipids (GSLs) are glycans linked to lipid molecules that together with sphingolipids, sterols, and proteins form plasma membrane lipid rafts that contribute to membrane integrity and provide specific recognition sites. GSLs are subdivided into three major series (globo-, ganglio-, and neolacto-series) and are synthesized in a non-template driven process by enzymes localized in the ER and Golgi apparatus. Altered glycosylation of lipids are known to be involved in tumor development and metastasis. Metastasis is frequently linked with reversible epithelial-to-mesenchymal transition (EMT), a process involved in tumor progression, and the formation of new distant metastatic sites (mesenchymal-to-epithelial transition or MET). On a single cell basis, cancer cells lose their epithelial features to gain mesenchymal characteristics via mechanisms influenced by the composition of the GSLs on the cell surface. Here, we summarize the literature on GSLs in the context of reversible and cancer-associated EMT and discuss how the modification of GSLs at the cell surface may promote this process.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [41] Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
    Zafari, Nima
    Velayati, Mahla
    Nassiri, Mohammadreza
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (28) : 2298 - 2311
  • [42] Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer
    Yamada, Suguru
    Fuchs, Bryan C.
    Fujii, Tsutomu
    Shimoyama, Yoshie
    Sugimoto, Hiroyuki
    Nomoto, Shuji
    Takeda, Shin
    Tanabe, Kenneth K.
    Kodera, Yasuhiro
    Nakao, Akimasa
    SURGERY, 2013, 154 (05) : 946 - 954
  • [43] Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
    Jones T. Nauseef
    Michael D. Henry
    Nature Reviews Urology, 2011, 8 : 428 - 439
  • [44] Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
    Krasnapolski, Martin A.
    Todaro, Laura B.
    de Kier Joffe, Elisa Bal
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (11) : 1891 - 1899
  • [45] Epithelial-to-mesenchymal transition and cancer-initiating cells
    Ouzounova, Maria
    Puisieux, Alain
    BULLETIN DU CANCER, 2017, 104 (12) : 1068 - 1071
  • [46] TGFβ signaling and epithelial-to-mesenchymal transition in prostate cancer
    Shenoy, Somanath P. R.
    Al-Azayzih, Ahmad
    Gao, Fei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S106 - S106
  • [47] Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
    Shakib, Heewa
    Rajabi, Sadegh
    Dehghan, Mohammad Hossien
    Mashayekhi, Farideh Jalali
    Safari-Alighiarloo, Nahid
    Hedayati, Mehdi
    ENDOCRINE, 2019, 66 (03) : 435 - 455
  • [48] Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma
    Lee, Sun-Jae
    Yang, Chun-Seok
    Kim, Dae-Dong
    Kang, Yu-Na
    Kwak, Sang Gyu
    Park, Jae-Bok
    Cho, Chang-Ho
    Park, Kwan-Kyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14257 - 14282
  • [49] Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
    Soon, Patsy S. H.
    Kim, Edward
    Pon, Cindy K.
    Gill, Anthony J.
    Moore, Katrina
    Spillane, Andrew J.
    Benn, Diana E.
    Baxter, Robert C.
    ENDOCRINE-RELATED CANCER, 2013, 20 (01) : 1 - 12
  • [50] Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis
    Loukia N Lili
    Lilya V Matyunina
    L DeEtte Walker
    Stephen L Wells
    Benedict B Benigno
    John F McDonald
    Journal of Ovarian Research, 6